16th Annual Scientific Meeting - Heart Failure Society of America
16th Annual Scientific Meeting - Heart Failure Society of America
16th Annual Scientific Meeting - Heart Failure Society of America
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Sept. 9<br />
Sunday<br />
PM<br />
SATELLITE SYMPOSIUM<br />
Sunday, September 9<br />
4:00-6:00 PM<br />
Ballroom 6A<br />
SATELLITE SYMPOSIUM<br />
Monday, September 10<br />
6:45-7:45 AM<br />
<strong>Meeting</strong> Room 608/609<br />
Sept. 10<br />
Monday<br />
AM<br />
sunday<br />
Achieving Treatment Success for Patients with<br />
<strong>Heart</strong> <strong>Failure</strong> Complicated by Hyponatremia<br />
Sleep Disordered Breathing in <strong>Heart</strong> <strong>Failure</strong>:<br />
Challenges and Opportunities<br />
Chair: John R. Teerlink, San Fancisco, CA<br />
4:00 Welcome and Introduction<br />
John R. Teerlink, San Francisco, CA<br />
4:10 Hypervolemic Hyponatremia in Patients with <strong>Heart</strong><br />
<strong>Failure</strong>: Pathogenesis and Treatment Options<br />
Joseph G. Verbalis, Washington, DC<br />
4:40 Lessons from Clinical Trials <strong>of</strong> Vasopressin Receptor<br />
Antagonists in <strong>Heart</strong> <strong>Failure</strong><br />
Marvin A. Konstam, Boston, MA<br />
5:05 Current and Emerging Treatment Options for<br />
Improving Outcomes in the <strong>Heart</strong> <strong>Failure</strong> Patient with<br />
Hyponatremia (Case #1)<br />
Paul J. Hauptman, St. Louis, MO<br />
5:30 Caring for the <strong>Heart</strong> <strong>Failure</strong> Patient with Hyponatremia:<br />
A Nursing Perspective (Case #2)<br />
Linda J. Ordway, Boston, MA<br />
5:50 Discussion with Faculty<br />
John R. Teerlink, San Francisco, CA<br />
6:00 Adjourn<br />
Learning Objectives:<br />
1. Review the role <strong>of</strong> arginine vasopressin in the<br />
pathogenesis <strong>of</strong> hypervolemic hyponatremia in patients<br />
with heart failure<br />
2. Assess the safety and efficacy <strong>of</strong> current and emerging<br />
therapies for the management <strong>of</strong> hyponatremia in patients<br />
with heart failure<br />
3. Discuss evidence-based guidelines and strategies on the<br />
management <strong>of</strong> hyponatremia in acute decompensated<br />
heart failure<br />
4. Apply evidence-based guidelines on the management <strong>of</strong><br />
hypervolemic hyponatremia in acute decompensated heart<br />
failure<br />
5. Discuss strategies to achieve treatment success for<br />
patients with heart failure and hyponatremia<br />
Chair:<br />
Christopher M. O’Connor, Durham, NC<br />
6:45 Introduction and Epidemiology <strong>of</strong> Sleep Disordered<br />
Breathing in <strong>Heart</strong> <strong>Failure</strong><br />
Christopher M. O’Connor, Durham, NC<br />
6:50 The Pathophysiology <strong>of</strong> Sleep Apnea in the <strong>Heart</strong> <strong>Failure</strong><br />
Patient<br />
Daniel J. Gottlieb, Boston, MA<br />
7:05 Sleep Apnea in <strong>Heart</strong> <strong>Failure</strong>: Key Elements <strong>of</strong> the<br />
Diagnostic Evaluation<br />
William T. Abraham, Columbus, OH<br />
7:15 Treatment Strategies for Sleep Disordered Breathing in<br />
<strong>Heart</strong> <strong>Failure</strong><br />
John S. Floras, Toronto, ON, CA<br />
7:30 Troubleshooting<br />
Sara C. Paul, Hickory, NC<br />
7:35 Panel Discussion and Questions<br />
Faculty<br />
7:45 Adjourn<br />
Learning Objectives:<br />
1. Identify the epidemiology and risk factors for sleep<br />
disordered breathing in heart failure patients.<br />
2. Discuss the mechanisms and pathophysiology <strong>of</strong> sleepdisordered<br />
breathing in patients with heart failure.<br />
3. Conduct an effective diagnostic work-up<br />
4. Use appropriate treatment strategies for heart failure<br />
patients with sleep-disordered breathing<br />
Supported by an educational grant from ResMed, Inc.<br />
Monday<br />
Supported by an educational grant from Otsuka <strong>America</strong><br />
Pharmaceuticals, Inc<br />
This symposium is not part <strong>of</strong> the scientific<br />
program as planned by the HFSA <strong>Scientific</strong><br />
Program Committee.<br />
6:00 Opening Reception<br />
2012 HFSA <strong>Annual</strong> <strong>Scientific</strong> <strong>Meeting</strong><br />
Exhibit Hall 4B<br />
38<br />
This program is not part <strong>of</strong> the scientific program<br />
as planned by the HFSA <strong>Scientific</strong> Program<br />
Committee.<br />
39
Change language